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Abstract 
Bisphenol A (BPA) is an endocrine-disrupting chemical (EDC) produced in huge 
quantities in the manufacture of polycarbonate plastics and epoxy resins. It is present in 
most humans in developed countries, acting as a xenoestrogen and it is considered an 
environmental risk factor associated to several diseases. Among the whole array of 
identified mechanisms by which BPA can interfere with physiological processes in 
living organisms, changes on ion channel activity is one of the most poorly understood.  
There is still little evidence about BPA regulation of ion channel expression and 
function. However, this information is key to understand how BPA disrupts excitable 
and non-excitable cells, including neurons, endocrine cells and  muscle cells. This 
report is the result of a comprehensive literature review on the effects of BPA on ion 
channels. We conclude that there is evidence to say that these important molecules may 
be key end-points for EDCs acting as xenoestrogens. However, more research on 
channel-mediated BPA effects is needed. Particularly, mechanistic studies to unravel the 
pathophysiological actions of BPA on ion channels at environmentally relevant doses. 
 
Abbreviations 
AMPA, α-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; BPA, Bisphenol A; ER, 
estrogen receptor; CFTR, Cystic fibrosis transmembrane conductance regulator; 
GABAA, Gamma-aminobutyric acid type A; EDCs, Endocrine-disrupting chemicals; 
GPR30 or GPER, G-protein coupled receptor 30 or G-protein coupled estrogen 
receptor; HEK, Human embryonic kidney cells; ICRAC, Ca2+ release-activated 
currents. NMDA, N-methyl-d-aspartate; o, p′-DDT, 4-Octylphenol p-nonylphenol 
dichlorodiphenyltrichloroethane; Orai1, Calcium release-activated calcium channel 
protein 1; RyR, Ryanodine receptors; tbBPA, TetrabromoBPA; TTX, Tetrodotoxin; 
TRP, Transient receptor potential. 
 
Keywords 
Bisphenol A, ion channel, endocrine disruptor, environmental doses, 17 β-Estradiol, 
pancreatic β-cells. 
 
Highlights 
► The effects of Bisphenol A (BPA) on ion channels are reviewed. 
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► The range of BPA experimental concentrations comprises from environmentally 
relevant doses of BPA to high doses of BPA, unusually found in humans. 
► The function of a plethora of ion channels are affected by BPA. 
► More systematic studies are needed to unravel the health related actions of BPA on 
ion channels at environmentally relevant doses. 
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1. Introduction 
During the last 20 years, a growing number of scientific studies have largely 
strengthened the evidence for endocrine health-related actions of endocrine-disrupting 
chemicals (EDCs). These currently widespread substances are defined by the Endocrine 
Society as: “an exogenous chemical, or mixture of chemicals, that interfere with any 
aspect of hormone action” [1]. These compounds can persist in the environment and, 
once they gain access to the human body, they can alter the hormonal milieu and affect 
many target tissues and physiological functions, being the translational evidence 
strongest for obesity and diabetes, female and male reproduction, hormone-sensitive 
cancers in females, prostate, thyroid and neurodevelopment and neuroendocrine systems 
[2].  Given that general population is exposed to a complex mixture of environmental 
chemicals, many of which are known EDCs, the potential human health risk is 
substantial and far beyond the relatively modest effect that each of these chemicals may 
have individually. 
 
Although there may be hundreds or more environmental chemicals with EDC activity, 
Bisphenol A (BPA) is one of the most commonly studied and one of the longest known, 
since it was discovered to be estrogenic in 1936 [3]. BPA is produced in higher amounts 
than any other chemical, with 15 billion pounds yielded in 2013 [4]. BPA is the building 
block of polycarbonate plastic, often used for food and beverage storage and a 
component of epoxy resins which are used to line food and beverage containers. Thus, 
food intake and drink are generally considered the major exposure route. The presence 
of BPA in our environment is ubiquitous and 93% of U.S. population has a measurable 
amount of BPA in their urine [5]. The mean BPA levels in human serum reported 
ranged from 4.3 ng/ml in children, 2.8 ng/ml in adolescents and 2.3-2.4 ng/ml in adults, 
although measurements of bioactive or free BPA in human serum is controversial at 
present. In addition, BPA has been detected in human amniotic fluid, neonatal blood, 
placenta, cord blood and human breast milk and interestingly BPA is fat-soluble and 
thus can accumulate in fatty tissues [6]. BPA is rapidly metabolized to nonbioactive 
forms and has a short half-life of approximately 4–5 hours in adult humans, with lower 
metabolic rates in the fetus and infants [7-9]. Currently, the US Environmental 
Protection Agency (EPA) safety level of BPA is set at 50 µg/kg/day, whereas the 
European Food Safety Authority’s temporary tolerable daily intake was recently 
lowered to 4 µg/kg/day. Risk assessments for BPA have  considered that oral exposure 
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is the main and almost exclusive exposure source, however, increasing evidence shows 
that additional routes like transdermal one, constitutes an important non-food source of 
BPA contamination [10, 11]. 
 
Estrogenic compounds like BPA are able to mimic the effect of the natural 
hormone17β-estradiol, at the same doses, and through common signaling pathways [12, 
13]. Estrogens, like other sex hormones, regulate the functioning of tissues in addition 
to those involved in reproduction in adults. This hormone plays an important role in the 
physiology of a variety of tissues including the brain, the reproductive and the 
cardiovascular system, directly modulating the function of many cells through activation 
of steroid receptive molecules, mainly the estrogen receptors α and β. In addition, some 
cells also express the G-protein coupled receptor for 17β-estradiol, named GPR30 or 
GPER (G-protein coupled estrogen receptor) [14, 15].  
Many of the actions of common intracellular signaling pathways, including those 
initiated by estrogens, are mediated by ion channels.Given the central role of ion 
channels in the physiology of the cell, it is not surprising that defects in the pathway that 
regulates channel function may contribute to the development of health disorders. 
Although it is well established that 17β-estradiol modulates several ion channels, both 
through classical genomic as well as rapid non-genomic pathways [16-18], the action of 
BPA at environmentally relevant doses it is still poorly investigated. 
The number of publications reporting the effect of BPA on ion channels in different cell 
types is still very scarce. It is of note that the doses used in many of these studies are 
usually at the micromolar range, which is a concentration not usually found in animal 
organisms.  In these conditions BPA may act through mechanisms other than activation 
of estrogen receptors, i.e: the direct docking of BPA moieties to the ion channel pore. 
These studies, although important, do not completely clarify the mechanisms through 
which the exposure to environmentally relevant doses of BPA alter the physiology of 
humans, as epidemiological studies suggest [19]. Strikingly, in most of these studies 
using high BPA concentrations, the dose response curve has not been completed to 
smaller doses. This is an important issue given the accepted fact that dose response are 
non-monotonic for many hormones and EDCs and low-dose effects seem to be the most 
relevant for BPA environmental disruption [20]. 
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The aim of this paper is to review the effects of BPA on ion channels described in the 
literature. We believe that it will encourage a more detailed study of the actions of BPA 
on ion channels at environmentally relevant doses and hence, bringing mechanistic 
insight into the suggested association between BPA exposure and health disorders. The 
table and figure below comprises a comprehensive summary of the effects of BPA on 
ion channels (table 1 and figure 1). The upper limit of environmentally relevant dose in 
the present review has been established as a maximal BPA administration of 500 
µg/Kg/day, which according to some pharmacokinetic studies, leads to a ratio of serum 
conjugated to unconjugated BPA within the range reported in human biomonitoring 
studies [21, 22]. Similarly, regarding BPA applied directly to a tissue/cell preparation, 
we have considered as physiologically relevant doses those in the nanomolar range (up 
to 100 nM). This “low-dose” cut-off has been defined by the Chapel Hill expert panel 
and has been widely adopted [23].  
In the sections below, different ion channel types are considered in relation to the 
reported actions of BPA on them. Furthermore, in order to illustrate the extent to which 
the interaction between BPA and ion channels may derive in actual human health 
disorders, we have included a final section about ion channel-mediated actions of BPA 
in pancreatic β-cells. Two reasons validate this choice:  the first one, that much work 
about ion channel regulation by estrogens and BPA has been developed in this cell type. 
The second reason is the strong translational evidence already accumulated for BPA 
exposure as a risk factor for obesity and diabetes [2, 13, 19]. 
2. BPA actions on Na+ channels 
Na+ channels play a central role transmitting depolarizing impulses rapidly throughout 
cells and cell networks, thereby enabling coordination of higher processes ranging from 
locomotion to cognition. 
Two electrophysiological studies have reported that high doses of BPA (micromolar 
range) inhibits voltage-gated Na+ channels (both TTX-sensitive and TTX-resistant 
channels) by direct binding of the BPA molecule to the channel [24, 25]. This indicates 
that BPA might have potential toxicological effects on the nervous system. In contrast, 
Belcher and coworkers have reported an increase in the mRNA expression of voltage-
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gated Na+ channel, Nav2.3 and Navβ4 (β subunit of Na+ channels) in the left ventricle 
of female mice with low doses of BPA (1 nM) that could account for altered 
cardiovascular functioning reported in epidemiological studies [2, 26]. 
3. BPA actions on K+ channels 
Voltage- and Ca2+-gated K+ channels (BK, maxiK or KCa1.1) are essential regulators of 
several key physiological processes including smooth muscle tone and neuronal 
excitability. Two studies have characterized the effect of high doses of BPA (1-100 µM) 
in this channel type in coronary smooth cells [27] and in transfected cells [28], revealing 
a direct channel activation by BPA via α and β1 subunits, similar to that of estradiol [18, 
29]. These data indicate that the increased activity of Maxi-K channels induced by BPA 
may represent a basis for potential toxicological effects. 
 
Another study by Ito and coworkers with high doses of BPA (100 µM) has reported a 
direct block of KcAMP (a K+ slow rectifier voltage-gated channel, modulated by cAMP) 
and of KCa (a Ca2+-gated K+ channel of intermediate conductance) in human airway 
epithelial cells, which interrupts CFTR-mediated Cl- secretion. This effect was caused 
independently of estrogen receptors, suggesting a binding site for BPA at high doses on 
both K+ channels [30]. 
 
Belcher and coworkers [26] have reported a decrease in the mRNA expression of 
several K+ channels: Kv1.1 and Kv1.6 (shaker-related voltage-gated K+ channels), Kir4.1 
(an inwardly rectifying K+ channel) and Mirp3 (a β subunit of voltage-gated K+ 
channels) in the left ventricle of male mice with low doses (1nM) of BPA that could 
account, as stated above, for the effect on Na+ channels on cardiovascular health. 
 
4. BPA actions on Ca2+ channels 
Ca2+ ions play crucial roles in regulating a variety of cellular functions in many different 
cell types. Several works have addressed the effect of BPA on different types of Ca2+ 
channels, including voltage-gated Ca2+ channels, ryanodine receptors (RyR), transient 
receptor potential (TRP) channels and Orai1 (Calcium release-activated calcium 
channel protein 1). Glutamate ionotropic receptors permeable to Ca2+ are commented in 
a section below. 
  
8 
 
Ca2+ channels in many different cell types activate with membrane depolarization and 
mediate Ca2+ influx in response to action potentials and subthreshold depolarizing 
signals. On the basis of their voltage dependence of activation, the voltage-gated Ca2+ 
channels fall into two broad groups: the low (T-type) and the high (L-, N-, P/Q- and R-
type) threshold  activated channels.  
A recent study reported an increase in mRNA expression of T-type voltage-gated Ca2+ 
channels induced by low doses of BPA in male mice reproductive system  and 
suggested that estrogen receptor signaling was necessary for this effect [31]. This action 
of BPA could account for the effects on reproductive function observed in 
epidemiological studies [2]. However, in human embryonic kidney 293 (HEK) cells 
expressing T-type Ca2+ channels, acute application of BPA at different doses (0.1 nM-
100 µM) inhibited the Ca2+ current through this channel. Although high doses were 
required for inhibition of Cav3.1/3.3 subtypes, lower doses (within the nanomolar range) 
were sufficient to inhibit Cav3.2 subtype [32] in concentrations in the range of those 
detected in human fluids and could be relevant for evaluation of health effects of BPA. 
 
An electrophysiological study  has reported that Ca2+ currents through native L-, N-, 
P/Q-, T-type Ca2+ channels in rat endocrine GH3 cells, mouse dorsal root ganglion 
neurons or cardiac myocytes, and recombinant human R-type Ca2+ channels expressed 
in HEK cells, were rapidly and reversibly inhibited by high doses of BPA with similar 
potency (EC50 values: 26–35 µM), acting directly on the channel protein [33]. In 
another study, the mRNA expression of an auxiliary subunit of the high threshold 
voltage-gated Ca2+ channel, Cacnα2δ2, was decreased in the left ventricle of male mice 
with low doses of BPA (1 nM) [26]. 
 
Another study with high doses of BPA (25-150 µM) proposed a model for non-genomic 
action of BPA in PC12 cells, demonstrating the participation of G-protein, cyclic 
AMP/PKA, N-type Ca2+ channels, and ryanodine-sensitive Ca2+ stores in BPA-induced 
increase in dopamine release [34]. 
 
Ryanodine receptors have been as well investigated in two other studies. A work using 
tetrabromoBPA (tbBPA), which is a commonly used brominated flame retardant to 
reduce the flammability of several products, reported an inhibition of RyRs in Sertoli 
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cells that may cause endocrine disruption and Ca2+ dysregulation in cells involved in 
spermatogenesis, although the doses of tbBPA used in this case were high (5-60 µM) 
[35]. Later, Gao and coworkers have reported that exposure to low doses of BPA (1 
nM) increased both the production of cAMP and the phosphorylation of RyRs by PKA 
through ERβ in cardiac ventricular myocytes. Phosphorylation of the RyR increases 
RyR open probability and Ca2+ release from sarcoplasmic reticulum. These results 
provide a mechanistic insight into BPA’s rapid proarrhythmic actions in female cardiac 
myocytes and contribute to assess the potential cardiac toxicity of BPA exposure [36]. 
 
To date, just one study has reported an effect of BPA on TRPs [37]. High doses of BPA 
(5000-50000 µg/kg/day) were given to pregnant mice from gestation day 6.5 to 16.5. 
mRNA expression and protein levels decreased for both TRPV5 and TRPV6 channels 
in the kidney and duodenum, suggesting that BPA regulates the expression of genes 
associated with Ca2+ transport in pregnant mice, which may result in decreased serum 
Ca2+ levels. 
 
Orai1 is a Ca2+ selective ion channel activated upon depletion of internal Ca2+ stores and 
it mediates the Ca2+ release-activated currents (ICRAC). A recent study has reported an 
increase in Orai1 protein levels induced by low doses of BPA (1-10 nM) in prostate 
cancer cells, leading to an amplification of the store operated Ca2+ entry and stimulating 
cancer cell migration [38]. These results provide novel insights into the molecular 
mechanisms involved in the effects of an environmental factor on cancer cells. 
 
5. BPA actions on Cl- channels and aquaporins  
Cl- channels are a functionally and structurally diverse group of anion selective channels 
involved in processes that include regulation of a broad array of features, like 
excitability in neurons, skeletal, cardiac and smooth muscle, cell volume regulation, 
transepithelial salt transport, acidification of internal and extracellular compartments, 
cell cycle and apoptosis. Cl- channels can be classified into voltage-sensitive, calcium-
activated, high (maxi) conductance channels, the cystic fibrosis transmembrane 
conductance regulator (CFTR) and volume regulated channels. Aquaporins are integral 
membrane proteins that operate as water transfer channels, widely conserved in 
bacteria, plants, and animals [39, 40]. 
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To date, only two studies have reported actions of environmentally relevant doses of 
BPA on Cl- channels and aquaporins. Administration of BPA (0.1-10-1000 ppm) to 
male mice in a trans-generational protocol increased the expression of CFTR channels 
and aquaporins in the reproductive system, producing a detrimental effect on the 
reabsorptive activity of epididymis that could affect male fertility [41]. In another study, 
low doses of BPA (1 nM) decreased the mRNA expression of the Cl- voltage-gated 
channel CLC1 in the left ventricle of male mice; conversely, aquaporin 7 expression 
was increased [26]. These results may account for cardiovascular health disorders, as 
stated above. 
6. Ionotropic glutamate receptors. 
Ionotropic glutamate receptors mediate fast excitatory synaptic transmission in the 
central nervous system and regulate a broad spectrum of processes in the brain, spinal 
cord, retina, and peripheral nervous system. Glutamate receptors play important roles in 
numerous neurological diseases and have attracted intense scrutiny. Several studies 
have investigated the effects of BPA on glutamate-gated ionotropic NMDA (N-methyl-
D-aspartate) and AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate) 
receptors [42, 43].  
 
The first study by Sato and coworkers reported an increased expression of NMDA 
GluN1 receptors in hippocampal slice cultures upon 1 nM BPA incubation for one day, 
which was not mediated by estrogen receptors. This effect exacerbated the neuronal 
damage caused by glutamate and upregulated the spine density of the apical portion of 
dendrites [44]. Later, in 2010, two papers reported a decrease of NMDA receptors in 
mice hippocampus. Prenatal and postnatal exposure to BPA at low doses (100-500 
µg/Kg/day) decreased NMDA (not subtype specified) and dopamine receptors, and 
induced anxiolytic behaviors as well as cognitive deficits [45]. At high doses (50-50000 
µg/Kg/day) BPA inhibited the expression of NMDA receptors GluN1, GluN2A and 
GluN2B and ERβ, impairing learning and memory [46] That same year, two other 
papers reported opposite effects of low doses of BPA on NMDA receptors in rat 
hippocampus: a decrease in the expression of NMDA receptors [47] and an increase in 
NMDA receptors GluN2B mediated by ERβ phosphorylation promoting dynamic 
changes in hippocampal dendritic morphology [48] A further paper by Xu and 
coworkers reported again an increase in the expression of NMDA receptors GluN1and 
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GluN2B mediated by non-genomic ER phosphorylation of receptors in rat 
hippocampus, thus enhancing passive avoidance memory [49]. Two other papers by the 
same group reported a decreased expression of NMDA and AMPA receptors in mice 
hippocampus using a transgenerational protocol of BPA administration (400-40000 
µg/Kg/day) inhibiting synaptogenesis  and sex-specific effects in memory and synaptic 
structure [50, 51]. It is remarkable that most of the effects of BPA on ionotropic 
glutamate receptors by Xu and coworkers were observed at doses relevant to human 
exposure. 
 
7. BPA actions on nicotinic receptors 
Nicotinic receptors are activated by the endogenous neurotransmitter acetylcholine and 
they are expressed by both neuronal and non-neuronal cells throughout the body. These 
receptors form ion channels permeable to cations, regulating physiological processes 
ranging from maintenance of metabolic tone, to control of inflammatory processes or 
their widely studied influence over inhibitory and excitatory transmissions in the 
nervous system. 
One of the first studies investigating the action on BPA was performed on neuronal 
α3β4 and α4β2 nicotinic receptors expressed in Xenopus oocytes using 
electrophysiological techniques [52]. High concentrations of BPA (0.1-100 µM) were 
acutely applied to these ion channels, producing a direct block that was independent of 
estrogen receptors. For this reason, it will here be considered a pharmacologic study, 
not representing the actual actions of BPA in human fluids, which hardly ever may 
achieve these high concentrations.  
8. BPA actions on GABA receptors 
GABA (gamma-aminobutyric acid) is an inhibitory neurotransmitter very widely 
distributed in brain neurons. GABA contributes to motor control, vision, and many 
other cortical functions. GABAA receptors are channel proteins allowing negatively 
charged Cl- ions to enter the neuron, thus reducing its excitability. 
The first study reporting an action of BPA on an ion channel was performed on GABAA 
receptors expressed in Xenopus oocytes [53]. BPA has dual actions on GABAA 
channels, depending on the concentration of BPA used: 0.1 mM BPA potentiates, and 1 
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mM BPA inhibits those currents generated by 10 µM GABA. It has to be noted, 
however, that these are extremely high concentrations of BPA and that the effect was 
induced by direct binding of BPA to GABAA channels, independently of estrogenic 
actions. Later, in 2007, another paper reported multiple effects of BPA on GABAA 
receptors in hippocampal neurons. Doses of BPA were high (3-300 µM) and the direct 
effect of BPA depended on the dose of GABA used to activate the channel. A high 
concentration of BPA potentiated the action of GABA at low doses and inhibited the 
effect of GABA at high doses [54].   
 
A study of perinatal administration of BPA at low doses reported an inhibition of 
GABAA currents in neurons of the amygdala, causing GABAergic disinhibition and 
dopaminergic enhancement, leading to an abnormal cortical-amygdala synaptic 
transmission and plasticity, which may be responsible for the hyperactivity and 
attention-deficit in BPA-exposed rats [55].  Finally, a recent paper has reported sex-
specific effects of long-term exposure to BPA on GABAA2 receptor levels in the 
hippocampus, increasing it in females and decreasing it in males. These results, together 
with an altered behavioral assay, suggest that long-term exposure to BPA affects 
anxiety- and depression-like behaviors in adult mice mediated by changes in the levels 
of GABAA2 receptor and ERβ proteins of hippocampus [56]. 
 
9. Ion channel regulation by estrogens and BPA in pancreatic β-cells 
 
Pancreatic β-cells are electrically excitable cells. They have a central role in glucose 
homeostasis and represent the most abundant cell type in the endocrine pancreas [57-
59]. The main task of pancreatic β-cells is the biosynthesis and release of insulin in 
response to an increase of plasma glucose concentration. Briefly, at low glucose 
concentrations, KATP channels are mostly in the open state and the cell membrane 
resting potential remains around -70mV.  However, when glucose levels increase, 
ATP/ADP ratio raises, leading to the closure of KATP channels. As a consequence, 
membrane potential depolarizes up to -40mV, opening voltage-dependent Ca2+ channels 
and increasing intracellular calcium [60, 61]. [Ca2+]i  and cyclic AMP oscillatory pattern 
originate, triggering a pulsatile insulin secretion  to counteract the rise in glucose 
plasma concentration [62-64]. As in neurons, estrogens and EDCs can modulate ion 
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channels in pancreatic β-cells. Here we give a summary of the thoroughly described 
effects of BPA on insulin-secreting cells. 
A key ion channel in pancreatic β-cells is the KATP channel. It plays a crucial role in 
stimulus-secretion coupling.  It is an octameric complex composed by four Kir6.2 and 
four sulfonylurea receptor SUR1 that comprises the regulatory subunit[14, 60, 65].  In 
physiological conditions ATP/ADP ratio, long-chain acyl CoA esters (LC-CoAs) and 
phosphatidylinositol-4,5- bisphosphate, among other intracellular factors, can modulate 
its activity [66]. However, it has been demonstrated that other compounds like estrogens 
can regulate its function in a non-genomic manner. Previous studies in mice 
demonstrated that physiological concentrations of 17β-estradiol (100 pM-1 nM), in 
synergy with glucose, decreased KATP channel activity via cGMP production, thus 
increasing [Ca2+]i  oscillations in a concentration-dependent manner. It was 
demonstrated that the receptor involved in this process was located ioutside the nucleus, 
and it waswas proposed to be different to the classical cytosolic estrogen receptors ERα 
and ERβ [67-69]. This non-classical membrane estrogen receptor could be GPER which 
is also expressed in β-cells [70].In 2009, however, Soriano et al. demonstrated that ERβ, 
but not ERα, rapidly modulated KATP channels. 17β-estradiol (1 nM) via ERβ, 
decreased KATP channel activity in a cGMP dependent manner. This mechanism 
potentiated calcium signalling and insulin secretion [71]. 
Additional effects of SUR1 subunit, besides regulating electrical activity, have been 
proposed. 17β-estradiol directly interacts with KATP channels modulating β-cell 
apoptosis under specific involvement of SUR1 in an age-dependent manner. Authors 
have shown that 100 µM 17β-estradiol treatment of pancreatic islets from mice aged 20-
22 weeks induced an increase in the apoptotic nuclei compared to control islets. 
However, when islets from young mice (5-7weeks) were treated, the number of 
apoptotic nuclei was clearly reduced. These effects were stronger at lower 
concentrations of estradiol [72].  
In addition to estrogens, other substances can modulate the KATP channel. Some 
“phytoestrogens” or endocrine-disrupting chemicals (EDCs) like BPA perturb ion 
channels in these cells mimicking the actions of the natural hormone, described above 
[13, 72, 73]. It is well accepted that EDCs exert their actions binding to the classical 
ERα and ERβ [74, 75] but most of the effects described through the classical pathway 
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occur at supraphysiological concentrations. In the same way as estrogens, EDCs can 
modulate β-cell function through alternative pathways [75-77].  
Recently, it has been demonstrated that 1 nM BPA has a rapid insulinotropic effect 
modulating KATP channel in mice and human β-cells. Application of environmentally 
relevant doses of BPA rapidly decreased KATP channel activity, stimulating insulin 
secretion[13].   
Finally, less is known about whether estrogen or BPA can modulate other ion channels 
present in pancreatic β-cell membranes. It has been demonstrated that physiological 
concentrations of estradiol directly potentiated L-type Ca2+ channels in hippocampal 
neurons [78]. Rapid effects of environmental pollutants, such as 4-octylphenol, 
nonylphenol, and o, p′-DDT, inhibited L-type Ca2+ channels in smooth muscle cells 
[79].This channel is present in pancreatic β-cell but until now it has not been tested for 
estrogen or xenoestrogen actions on this cell type. 
 
9. Concluding remarks 
BPA is an EDC ubiquitously present in human populations of advanced countries, 
acting as a xenoestrogen and associated in epidemiological studies to the alteration of 
many physiological functions, being the evidence strong for metabolism, reproduction, 
development and neuroendocrine regulation. In these physiological processes, ion 
channels are of crucial importance as they initiate or act as effectors in many signaling 
pathways. We review here the reported effects of BPA on ion channels in the literature 
and come to the conclusion that there is evidence that BPA alters ion channel function 
in excitable cells. This is a crucial mechanism to understand the alterations that BPA 
exerts in nervous system development as well as in other excitable cells in endocrine 
and cardiovascular systems. 
Nevertheless, the number of publications reporting the effect of BPA on these important 
signaling molecules in different cell types is still scarce. Approximately, half of these 
reports used low doses of BPA usually found in humans that could account for some of 
the molecular mechanism linking BPA exposure to health related problems, as 
epidemiological studies suggest. The rest of reports, however, employed high doses of 
BPA not usually found in humans and hence not contributing to clarify these 
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mechanisms. We conclude that several studies demonstrate that BPA modulates the 
function of numerous ion channels that play a central role on several neurological, 
endocrine and metabolic diseases. More systematic mechanistic research on ion 
channel-mediated BPA effects at environmentally relevant doses is still needed. 
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Ref Animal 
species 
Tissue BPA 
administration 
Ion channel type 
 
Measurement 
technique 
Effect Cell signalling Environmental 
relevant dose 
Proposed physiological 
system affected 
[31] Mice ♂ Testis 
Epididymis 
100 µg/Kg/d (30 
d). Intragastric 
T-type LVA Ca2+ channel 
(Cav3.1, Cav3.2, Cav3.3) 
mRNA expression ↑ (Cav3.1, 
Cav3.2, Cav3.3) 
(testis) 
↑ (Cav3.1, 
Cav3.2, 
(Epididymis) 
↓Cav3.3) 
(Epididymis) 
ERβ testis and 
Cav3.3 
epididymis 
 
ERα & β (Cav3.1, 
Cav3.2, 
epididymis 
Yes Male reproductive 
function 
[26] Mice 
♂ & ♀ 
Cardiac 
(left ventricle) 
5-5000 µg/Kg/d 
(90 d). Diet  
-Aqp7 (aquaporin 7) 
-Cacnα2δ2 (auxiliary subunit of 
HVA Ca2+ channel) 
-ClC1 (Cl- voltage-gated channel) 
-Kv1.1 (K+ voltage-gated channel, 
shaker-related) 
-Kv1.6 (K+ voltage-gated channel, 
shaker-related) 
-Mirp3 (β subunit of K+ voltage-
gated channels) 
-Kir4.1 (K+ inward rectifier 
channel) 
-Navβ4 (β subunit of Na+ channels) 
-Nav2.3 (Na+ voltage-gated 
channel) 
mRNA expression -↑ ♂ 
-↓ ♂ 
 
-↓ ♂ 
-↓ ♂ 
 
-↓ ♂ 
 
-↓ ♂ 
 
-↓ ♂ 
 
-↑ ♀ 
-↑ ♀ 
N/M Yes Cardiovascular system 
[56] Mice 
♂ & ♀ 
Brain  
(hippocampus) 
4-40000 µg/Kg/d  
(84 d). Oral 
GABAA2 Protein levels  
(Western blot) 
-↑ ♀ 
-↓ ♂ 
N/M Yes ♀ 
No ♂ 
Brain (anxiety & 
depression) 
[28]  Transfected 
cells (AD 293) 
1-100 µM  (acute 
application) 
hSlo α and β1 subunits of BK 
channel (K+ voltage- & Ca2+-gated 
channel) 
Electrophysiology -↑ Direct opening No Several 
[32] Human Transfected 
cells (HEK 
293) 
0.1nM-100 µM 
(acute 
application) 
T-type LVA Ca2+ channel 
(Cav3.1, Cav3.2, Cav3.3) 
Electrophysiology -↓ N/M Yes Cav3.2 
No Cav3.1/3.3 
Brain  
Cardiovascular system 
[36] Rat Cardiac 
(ventricular 
myocites) 
1 nM (acute 
application) 
RyR (ryanodine receptor) Protein levels  
(Western blot) 
-↑ ERβ (PKA) Yes Cardiovascular system 
(arrhythmias) 
[41] Mice 
♂ 
(trans-
generational 
protocol) 
Testis 
Epididymis 
0.1-10-1000 ppm 
(drinking water) 
to generation F0 
(30 d)  and F1-F2 
for the entire 
experimental 
period 
-Cftr (Cl- channel; Cystic fibrosis 
transmembrane conductance 
regulator) 
 
-Aqp1 (aquaporin 1) 
 
-Aqp9 (aquaporin 1) 
mRNA expression -↑ (0.1-1000 
ppm) 
 
 
-↑ (0.1-1000 
ppm) 
-↑ (10 ppm) 
N/M Yes (0.1 ppm-10 
ppm) 
Male reproductive 
function (infertility) 
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Ref Animal 
species 
Tissue BPA 
administration 
Ion channel type 
 
Measurement 
technique 
Effect Cell signalling Environmental 
relevant dose 
Proposed physiological 
system affected 
[50] Mice 
♂ & ♀ 
Brain  
(hippocampus) 
400, 4000 ,40000 
µg/Kg/d (84 d). 
Oral 
-GluN1 (NMDA) 
-GluR1 (AMPA) 
Protein levels  
(Western blot) 
-↓ 
-↓ 
N/M Yes Brain 
[51] Mice 
♂ 
(trans-
generational 
protocol) 
Brain  
(hippocampus) 
400-40000 
µg/Kg/d (from 
GD7 to PND21). 
Oral 
-GluN1 (NMDA) 
-GluR1 (AMPA) 
Protein levels  
(Western blot) 
-↓ 
-↓ 
N/M Yes 
No 
Brain 
[38]   Transfected 
cells 
(LNCaP & 
PC-3 PCa) 
1-10 nM  
(24-48 h 
incubation) 
Orai1 Protein levels  
(Immunofluorescence 
and Western blot) 
Ca2+ fluorescence 
-↑ N/M Yes Cancer cells 
(Prostate) 
[33] Rat GH3, 
DRG and 
cardiac 
myocytes & 
HEK 293 
cells  
Native and 
transfected 
cells 
10-70 µM  
(acute 
application) 
-L, P/Q and  R-type HVA Ca2+ 
channels (GH3) 
-N and T-type HVA Ca2+ channels 
(DRG) 
-L-type HVA Ca2+ channels 
(cardiac myocytes) 
-R-type HVA Ca2+ channels (HEK) 
Electrophysiology -↓ 
 
-↓ 
 
-↓ 
 
-↓ 
Direct block No Endocrine, cardiac and 
neuronal cells 
[37] Pregnant 
Mice 
♀ 
Kidney  
Duodenum 
5000-50000 
µg/Kg/d (from 
GD6.5 to 
GD16.5). Oral 
-TRPV6 
-TRPV5 
mRNA expression 
Protein levels  
(Western blot) 
-↓ 
-↓ 
 
N/M No Ca2+ homeostasis 
[24]  Transfected 
cells (HEK 
293) 
1-10000 µM 
(acute 
application) 
hNav1.5 (Na+ voltage-gated 
channel) 
Electrophysiology -↓ 
 
Direct block No Cardiovascular system 
[13] Mice ♀ & 
Human 
islets 
Pancreatic β-
cells 
1 nM (acute 
application) 
Kir6.2 (KATP channel) Electrophysiology -↓ 
 
ERβ Yes Endocrine 
System 
[49] Rat ♂ 
 
Brain  
(hippocampus) 
50-500 µg/Kg 
(1-24 h 
treatment) 
GluN1 & GluN2B (NMDA) Protein levels  
(Western blot) 
-↑  
(1h treatment) 
(No effect 24h 
treatment) 
ERs (non-
genomic effects; 
phosphorylation) 
Yes Brain 
[55] Rats 
♀ & ♂ 
 
Brain 
(amigdala) 
2 µg/Kg/day 
(subcutaneous 
from GD10 to 
PND7) 
GABAA Electrophysiology -↓ 
 
N/M Yes Brain 
[25] Mice 
♂ 
 
Dorsal Root 
Ganglion 
neurons 
40µM (acute 
application) 
-TTX-sensitive Na+ channels 
-TTX-resistant Na+ channels 
Electrophysiology -↓ 
-↓ 
 
-Direct block 
-Block  
(dependent on 
PKC & PKA) 
No Neuronal cells 
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Ref Animal 
species 
Tissue BPA 
administration 
Ion channel type 
 
Measurement 
technique 
Effect Cell signalling Environmental 
relevant dose 
Proposed physiological 
system affected 
[48] Rats Brain  
(hippocampus) 
1-1000 nM 
(acute 
application) 
GluN2B (NMDA) 
 
Immunocytochemistry 
Protein Levels 
(Western blot) 
-↑ 
 
ERβ 
(phosphorylation) 
Yes Brain 
[47] Rats 
♀ & ♂ 
 
Brain  
(hippocampus) 
50-200000 
µg/Kg/day 
(oral exposure 
from GD7 to 
PND21) 
GluN1, GluN2A & GluN2B 
(NMDA) 
Protein levels  
(Western blot) 
-↓ (low & high 
doses) 
ERβ Yes Brain 
[27] Human & 
canine cells 
AD-293 
cells 
coronary 
smooth cell 
10-100µM 
(acute 
application) 
hSlo α and β1 subunits of BK 
channel (K+ voltage- & Ca2+-gated 
channel) 
Electrophysiology -↑ Direct opening (β1 
subunit) 
No Cardiovascular system 
[46] Mice 
♀ & ♂ 
 
Brain  
(hippocampus) 
 
500,5000 & 
50000 µg/Kg/day 
(oral exposure 
from GD7 to 
PND21) 
GluN1, GluN2A & GluN2B 
(NMDA) 
Polyacrylamide gel 
electrophoresis 
-↓ N/M No Brain 
[45] Mice 
♀ & ♂ 
 
Brain  
(hippocampus) 
100 & 500 
µg/Kg/day 
(oral exposure 
from GD7 to  
PND21) 
NMDA Receptor 
(not subtype specified) 
Autorradiographic 
receptor binding assay 
-↓ N/M Yes Brain 
[35] Mice ♂ 
 
Sertoli cells 5-60µM 
(acute 
application) 
RyR Ca2+ fluorescence ↑ RyR (0.4-
4µM) 
Direct opening No Reproductive 
system 
[54] Rat Brain  
(hippocampus) 
3-300 µM 
(acute application 
to dissociated) 
GABAA Electrophysiology -↑ (low 
[GABA]) 
-↓ (high 
[GABA]) 
Direct No Brain 
[34]  PC12 cells 
(adrenal gland 
tumour) 
25-150 µM 
(acute 
application) 
-N-type HVA Ca2+ channels 
-RyR 
Measurement of 
dopamine release with 
HPLC 
-↑ 
-↑ 
Non genomic 
action on G-
proteins and PKA 
activation 
No Cancer cells 
(Adrenal) 
[44] Rat  
 
 
 
Organotypic 
hippocampal 
slice cultures  
(PD8) 
1 nM  
(24 h incubation) 
GluN1 (NMDA)  Immunohistochemistry -↑ (expression) 
in CA3 
No mediated by 
ERs 
Yes Brain 
[30] Human 
 
Airway 
epithelial 
Calu-3 cells 
100 µM  
(30 min  
pretreatment 
of cells) 
-KcAMP (K+ voltage-gated channel, 
slow rectifier modulated by cAMP) 
-KCa intermediate conductance 
Electrophysiology -↓ 
 
-↓ 
 (no effects in 
12-72 h of BPA 
incubation) 
Direct block No Respiratory system 
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Table 1. Summary of the effects of BPA on ion channels reported in the literature.  0 
The numbers in the Reference column (Ref) refer to the study cited in the Bibliography. The effect of BPA on ion channel is indicated with an up 1 
arrow (↑) or a down arrow (↓) for an upregulation of the activity or expression of the ion channel or a downregulation of the activity or 2 
expression of the ion channel, respectively.  Abbreviations: BPA: Bisphenol A; ER: Estrogen receptor; GD: gestation day; HVA: High voltage-3 
activated; LVA: Low voltage-activated; N/M: Not measured; PND: post-natal day; NMDA: N-methyl-D-aspartate; RyR: Ryanodine receptor.4 
Ref Animal 
species 
Tissue BPA 
administration 
Ion channel type 
 
Measurement 
technique 
Effect Cell signalling Environmental 
relevant dose 
Proposed physiological 
system affected 
[52] Human Transfected 
cells (Xenopus 
oocytes) 
0.1-100 µM 
(acute 
application) 
Nicotinic receptors α3β4 & α4β2 
 
Electrophysiology -↓  
 
Direct block No Brain 
[53] Rat & 
Bovine 
Transfected 
cells (Xenopus 
oocytes) 
0.1-1 mM 
(acute 
application) 
GABAA Electro 
physiology 
-↑ (0.1 mM 
BPA) 
-↓ (1 mM BPA) 
Direct No Brain 
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Figure 1.Hypothetical cell expressing all ion channels modulated by BPA. Up arrows 
indicate upregulation of the activity or expression of the ion channel by BPA and down 
arrows indicate a downregulation of the activity or expression of the ion channel by 
BPA. Numbers indicate the reference where these effects were reported (see 
bibliography). 
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